These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
534 related articles for article (PubMed ID: 23139086)
1. A unique matched quadruplet of terbium radioisotopes for PET and SPECT and for α- and β- radionuclide therapy: an in vivo proof-of-concept study with a new receptor-targeted folate derivative. Müller C; Zhernosekov K; Köster U; Johnston K; Dorrer H; Hohn A; van der Walt NT; Türler A; Schibli R J Nucl Med; 2012 Dec; 53(12):1951-9. PubMed ID: 23139086 [TBL] [Abstract][Full Text] [Related]
2. DOTA conjugate with an albumin-binding entity enables the first folic acid-targeted 177Lu-radionuclide tumor therapy in mice. Müller C; Struthers H; Winiger C; Zhernosekov K; Schibli R J Nucl Med; 2013 Jan; 54(1):124-31. PubMed ID: 23236020 [TBL] [Abstract][Full Text] [Related]
3. Promises of cyclotron-produced 44Sc as a diagnostic match for trivalent β--emitters: in vitro and in vivo study of a 44Sc-DOTA-folate conjugate. Müller C; Bunka M; Reber J; Fischer C; Zhernosekov K; Türler A; Schibli R J Nucl Med; 2013 Dec; 54(12):2168-74. PubMed ID: 24198390 [TBL] [Abstract][Full Text] [Related]
4. Direct in vitro and in vivo comparison of (161)Tb and (177)Lu using a tumour-targeting folate conjugate. Müller C; Reber J; Haller S; Dorrer H; Bernhardt P; Zhernosekov K; Türler A; Schibli R Eur J Nucl Med Mol Imaging; 2014 Mar; 41(3):476-85. PubMed ID: 24100768 [TBL] [Abstract][Full Text] [Related]
5. Future prospects for SPECT imaging using the radiolanthanide terbium-155 - production and preclinical evaluation in tumor-bearing mice. Müller C; Fischer E; Behe M; Köster U; Dorrer H; Reber J; Haller S; Cohrs S; Blanc A; Grünberg J; Bunka M; Zhernosekov K; van der Meulen N; Johnston K; Türler A; Schibli R Nucl Med Biol; 2014 May; 41 Suppl():e58-65. PubMed ID: 24360901 [TBL] [Abstract][Full Text] [Related]
6. Promising prospects for 44Sc-/47Sc-based theragnostics: application of 47Sc for radionuclide tumor therapy in mice. Müller C; Bunka M; Haller S; Köster U; Groehn V; Bernhardt P; van der Meulen N; Türler A; Schibli R J Nucl Med; 2014 Oct; 55(10):1658-64. PubMed ID: 25034091 [TBL] [Abstract][Full Text] [Related]
7. Synthesis and Preclinical Evaluation of Folate-NOTA-Al(18)F for PET Imaging of Folate-Receptor-Positive Tumors. Chen Q; Meng X; McQuade P; Rubins D; Lin SA; Zeng Z; Haley H; Miller P; González Trotter D; Low PS Mol Pharm; 2016 May; 13(5):1520-7. PubMed ID: 27054811 [TBL] [Abstract][Full Text] [Related]
8. In vivo imaging of folate receptor positive tumor xenografts using novel 68Ga-NODAGA-folate conjugates. Fani M; Tamma ML; Nicolas GP; Lasri E; Medina C; Raynal I; Port M; Weber WA; Maecke HR Mol Pharm; 2012 May; 9(5):1136-45. PubMed ID: 22497506 [TBL] [Abstract][Full Text] [Related]
9. Preclinical evaluation of isostructural Tc-99m- and Re-188-folate-Gly-Gly-Cys-Glu for folate receptor-positive tumor targeting. Kim WH; Kim CG; Kim MH; Kim DW; Park CR; Park JY; Lee YS; Youn H; Kang KW; Jeong JM; Chung JK Ann Nucl Med; 2016 Jun; 30(5):369-79. PubMed ID: 26993818 [TBL] [Abstract][Full Text] [Related]
11. SPECT study of folate receptor-positive malignant and normal tissues in mice using a novel 99mTc-radiofolate. Müller C; Forrer F; Schibli R; Krenning EP; de Jong M J Nucl Med; 2008 Feb; 49(2):310-7. PubMed ID: 18199624 [TBL] [Abstract][Full Text] [Related]
12. Scandium and terbium radionuclides for radiotheranostics: current state of development towards clinical application. Müller C; Domnanich KA; Umbricht CA; van der Meulen NP Br J Radiol; 2018 Nov; 91(1091):20180074. PubMed ID: 29658792 [TBL] [Abstract][Full Text] [Related]
13. Preclinical in vivo application of (152)Tb-DOTANOC: a radiolanthanide for PET imaging. Müller C; Vermeulen C; Johnston K; Köster U; Schmid R; Türler A; van der Meulen NP EJNMMI Res; 2016 Dec; 6(1):35. PubMed ID: 27108447 [TBL] [Abstract][Full Text] [Related]
14. Development of a New Folate-Derived Ga-68-Based PET Imaging Agent. Brand C; Longo VA; Groaning M; Weber WA; Reiner T Mol Imaging Biol; 2017 Oct; 19(5):754-761. PubMed ID: 28194631 [TBL] [Abstract][Full Text] [Related]
15. (64)Cu- and (68)Ga-Based PET Imaging of Folate Receptor-Positive Tumors: Development and Evaluation of an Albumin-Binding NODAGA-Folate. Farkas R; Siwowska K; Ametamey SM; Schibli R; van der Meulen NP; Müller C Mol Pharm; 2016 Jun; 13(6):1979-87. PubMed ID: 27145400 [TBL] [Abstract][Full Text] [Related]
17. Fluorine-18 click radiosynthesis and preclinical evaluation of a new 18F-labeled folic acid derivative. Ross TL; Honer M; Lam PY; Mindt TL; Groehn V; Schibli R; Schubiger PA; Ametamey SM Bioconjug Chem; 2008 Dec; 19(12):2462-70. PubMed ID: 19053298 [TBL] [Abstract][Full Text] [Related]
18. Tumor targeting using 67Ga-DOTA-Bz-folate--investigations of methods to improve the tissue distribution of radiofolates. Müller C; Vlahov IR; Santhapuram HK; Leamon CP; Schibli R Nucl Med Biol; 2011 Jul; 38(5):715-23. PubMed ID: 21718947 [TBL] [Abstract][Full Text] [Related]
19. Comparative Studies of Three Pairs of α- and γ-Conjugated Folic Acid Derivatives Labeled with Fluorine-18. Boss SD; Betzel T; Müller C; Fischer CR; Haller S; Reber J; Groehn V; Schibli R; Ametamey SM Bioconjug Chem; 2016 Jan; 27(1):74-86. PubMed ID: 26634288 [TBL] [Abstract][Full Text] [Related]